Osteoporosis and other complications of inflammatory bowel disease

Current Opinion in Gastroenterology

Volumn 18, Issue 4, 2002, Pages 428-434

  Bernstein, Charles N ^a  

^a John Buhler Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYLOSING SPONDYLITIS; CROHN DISEASE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; ERYTHEMA NODOSUM; HUMAN; INCIDENCE; IRITIS; OSTEOPENIA; OSTEOPOROSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; ULCERATIVE COLITIS; UVEITIS;

EID: 0036087299     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200207000-00006     Document Type: Review

References (30)

1. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
2. The incidence of fractures among patients with IBD: A population-based study
3. Risk of fracture in Crohn's disease: A population based study
4. Osteoprotegerin ligand: A regulator of immune responses and bone physiology
5. Genetic factors determine extent of bone loss in inflammatory bowel disease
6. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
7. The incidence of venous thromboembolic disease among patients with IBD: A population-based study
8. Inflammatory bowel disease promotes venous thrombosis earlier in life
9. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis
10. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels
11. Hyperhomocysteinemia and inflammatory bowel disease: Prevalence and predictors in a cross-sectional study
12. Terminal ileum resection is associated with higher plasma homocysteine levels in Crohn's disease
13. Homocysteine in inflammatory bowel disease: A risk factor for thromboembolic complications?
14. Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis
15. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease
16. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study
17. The epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study
18. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease
19. Twenty cases of peristomal pyoderma gangrenosum: Diagnostic implications and management
20. Clinical features and treatment of peristomal pyoderma gangrenosum
21. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins
22. "Atypical p-ANCA" in IBD and hepatobiliary disorders reacts with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines
23. A preliminary trial of high dose ursodeoxycholic acid in primary sclerosing cholangitis
24. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis
25. Concurrence of inflammatory bowel disease and multiple sclerosis
26. Mesalazine-associated interstitial nephritis
27. Late onset interstitial nephritis associated with mesalazine treatment
28. Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine
29. Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis
30. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease